Stock RAY B RAYSEARCH LABORATORIES AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials RaySearch Laboratories AB

Equities

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:56 2024-04-26 am EDT 		5-day change 1st Jan Change
117 SEK +2.45% Intraday chart for RaySearch Laboratories AB +2.63% +29.57%
Apr. 11 National Institutes for Quantum Science and Technology Selects RaySearch Laboratories AB for Clinical Use at the QST Hospital CI
Feb. 23 Transcript : RaySearch Laboratories AB, 2023 Earnings Call, Feb 23, 2024

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 3,308 3,675 2,835 1,937 2,331 4,011 4,011 -
Enterprise Value (EV) 1 3,328 3,732 2,813 2,397 2,727 3,281 4,094 3,937
P/E ratio 42.1 x 72.9 x -318 x -40.9 x 98.6 x 37.9 x 31.7 x 23.7 x
Yield - - - - - 0.78% 1.28% 1.28%
Capitalization / Revenue 5.27 x 4.96 x 4.35 x 3.02 x 2.76 x 3.03 x 3.53 x 3.19 x
EV / Revenue 5.31 x 5.03 x 4.32 x 3.74 x 3.23 x 3.21 x 3.61 x 3.13 x
EV / EBITDA 16 x 14.9 x 13.4 x 12.2 x 8.03 x 8.2 x 8.56 x 7.24 x
EV / FCF -73,695,825 x 34,509,060 x 26,556,638 x 234,443,771 x - - - -
FCF Yield -0% 0% 0% 0% - - - -
Price to Book 5.03 x 5.21 x 4.08 x 2.98 x 3.55 x 4.21 x 5.06 x 4.4 x
Nbr of stocks (in thousands) 34,283 34,283 34,283 34,283 34,283 34,283 34,283 -
Reference price 2 96.50 107.2 82.70 56.50 68.00 117.0 117.0 117.0
Announcement Date 2/20/19 2/14/20 2/23/21 2/23/22 2/28/23 2/23/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 627.2 741.6 651.6 641.1 843.6 1,022 1,135 1,259
EBITDA 1 208.3 250.7 209.8 196.7 339.7 400.1 478.5 543.4
EBIT 1 94.5 68.2 -3.466 -53.5 42.7 114.9 169.3 224.1
Operating Margin 15.07% 9.2% -0.53% -8.35% 5.06% 11.24% 14.91% 17.8%
Earnings before Tax (EBT) 1 90.76 62.61 -6.478 -58.86 32.38 110.1 164.5 219.3
Net income 1 78.5 50.4 -9.08 -47.3 23.8 81.57 126.6 168.9
Net margin 12.52% 6.8% -1.39% -7.38% 2.82% 7.98% 11.15% 13.41%
EPS 2 2.290 1.470 -0.2600 -1.380 0.6900 2.380 3.690 4.930
Free Cash Flow -45.15 108.1 105.9 10.22 - - - -
FCF margin -7.2% 14.58% 16.25% 1.59% - - - -
FCF Conversion (EBITDA) - 43.14% 50.48% 5.2% - - - -
FCF Conversion (Net income) - 214.57% - - - - - -
Dividend per Share 2 - - - - - 0.7000 1.500 1.500
Announcement Date 2/20/19 2/14/20 2/23/21 2/23/22 2/28/23 2/23/24 - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 19.3 56.9 - 460 396 186 82.5 -
Net Cash position 1 - - 22.4 - - - - 74.3
Leverage (Debt/EBITDA) 0.0927 x 0.2268 x - 2.338 x 1.165 x 0.4642 x 0.1724 x -
Free Cash Flow -45.2 108 106 10.2 - - - -
ROE (net income / shareholders' equity) 12.7% 7.4% -1.3% -7% 3.7% 11.7% 16.6% 19.8%
ROA (Net income/ Total Assets) 7.77% - - - - - - -
Assets 1 1,010 - - - - - - -
Book Value Per Share 2 19.20 20.60 20.30 18.90 19.20 21.50 23.10 26.60
Cash Flow per Share - - - - - - - -
Capex 1 224 47.2 - 77.8 - 24.3 26.7 29.4
Capex / Sales 35.65% 6.36% - 12.14% - 2.38% 2.35% 2.33%
Announcement Date 2/20/19 2/14/20 2/23/21 2/23/22 2/28/23 2/23/24 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for RaySearch Laboratories AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
117 SEK
Average target price
135 SEK
Spread / Average Target
+15.38%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
RAYSEARCH LABORATORIES AB Stock RaySearch Laboratories AB
+29.57% 366M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
SECTRA AB Stock Sectra AB
+22.93% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.15B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. RAY B Stock
  4. Financials RaySearch Laboratories AB